# A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

> clinical trial · VERIFIED · 2026-07-13

Status: RECRUITING · Sponsor: Akebia Therapeutics · Condition: Focal Segmental Glomerulosclerosis

- Company: Akebia Therapeutics
- Sector: Focal Segmental Glomerulosclerosis
- Primary source: https://clinicaltrials.gov/study/NCT07268638

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.